Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ashraf Abu Jama"'
Autor:
Walid Shalata, Omar Abu Saleh, Lena Tourkey, Sondos Shalata, Ala Eddin Neime, Ali Abu Juma’a, Arina Soklakova, Lama Tourkey, Ashraf Abu Jama, Alexander Yakobson
Publikováno v:
Cancers, Vol 16, Iss 16, p 2909 (2024)
As the legalization of medical cannabis expands across several countries, interest in its potential advantages among cancer patients and caregivers is burgeoning. However, patients seeking to integrate cannabis into their treatment often encounter fr
Externí odkaz:
https://doaj.org/article/45755b66683747229c430b0d8806d6b2
Autor:
Walid Shalata, Ashraf Abu Jama, Yulia Dudnik, Omar Abu Saleh, Sondos Shalata, Lena Tourkey, Kim Sheva, Amichay Meirovitz, Alexander Yakobson
Publikováno v:
Medicina, Vol 60, Iss 8, p 1270 (2024)
Recent advancements in targeted therapies for non-small-cell lung cancer (NSCLC), specifically focusing on epidermal growth factor receptor (EGFR) mutations, have revolutionized treatment strategies. Osimertinib, an approved therapy for metastatic NS
Externí odkaz:
https://doaj.org/article/833e69e8065c4b8294cd11b9b3ba10b5
Autor:
Walid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, Alexander Yakobson, Yulia Dudnik, Ashraf Abu Jama, Ahron Yehonatan Cohen, Sondos Shalata, Ahmad Abu Hamed, Tahel Ilan Ber, Oshri Machluf, Gal Shoham Levin, Amichay Meirovitz
Publikováno v:
Cancers, Vol 16, Iss 10, p 1825 (2024)
The efficacy of immune checkpoint inhibitor (ICI) therapy concerning programmed death ligand 1 (PD-L1) status is well established in patients diagnosed with non-small cell lung cancer (NSCLC). However, there remains a paucity of evidence regarding th
Externí odkaz:
https://doaj.org/article/d24d3ce74dc94deb92372f0e05ebaba8
Autor:
Walid Shalata, Rachel Steckbeck, Amjad Abu Salman, Omar Abu Saleh, Ashraf Abu Jama, Zoé Gabrielle Attal, Sondos Shalata, Hilmi Alnsasra, Alexander Yakobson
Publikováno v:
Medicina, Vol 60, Iss 2, p 224 (2024)
Patient prognoses have been significantly enhanced by immune checkpoint inhibitors (ICIs), altering the standard of care in cancer treatment. These novel antibodies have become a mainstay of care for metastatic non-small-cell lung cancer (mNSCLC) pat
Externí odkaz:
https://doaj.org/article/74e2eeb3d30440a99b6c3f110a08cd85
Autor:
Walid Shalata, Zoé Gabrielle Attal, Rajeh Shhadi, Amjad Abu Salman, Ashraf Abu Jama, Sondos Shalata, Kais Halumi, Alexander Yakobson
Publikováno v:
Medicina, Vol 59, Iss 11, p 1946 (2023)
Many different types of cancer can be treated with immunotherapy drugs called immune checkpoint inhibitors (ICIs). These drugs have altered the landscape of cancer treatment options since they function by triggering a stronger immune response to mali
Externí odkaz:
https://doaj.org/article/b3f700134e9f408c8ce8fb5ca9107664
Autor:
Walid Shalata, Ashraf Abu Jama, Amjad Abu Salman, Mitchell Golosky, Adam Solomon, Omar Abu Saleh, Regina Michlin, Sondos Shalata, Abed Agbarya, Alexander Yakobson
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 20, p 6447 (2023)
Case studies of rare oncologic metastases are an important source of clinical data for health care professionals and researchers. While infrequent, the knowledge base and clinical recommendations derived from such cases aid in advancements in the fie
Externí odkaz:
https://doaj.org/article/fa8f2a11241a40bfbed12c84e85213a9
Autor:
Walid Shalata, Rachel Steckbeck, Ilya Polishchuk, Ahron Yehonatan Cohen, Keren Rouvinov, Margarita Tokar, Ashraf Abu Jama, Omar Abu Saleh, Kim Sheva, Alexander Yakobson
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
This case report describes the occurrence of hyperbilirubinemia as a complication of metastatic melanoma. A 72-year-old male patient was diagnosed with BRAF V600E-mutated melanoma with metastases in the liver, lymph nodes, lungs, pancreas, and stomac
Externí odkaz:
https://doaj.org/article/cffe25d51cba484f9b2a30327de7f0da
Autor:
Walid Shalata, Alexander Yakobson, Yulia Dudnik, Forat Swaid, Mohammad Sheikh Ahmad, Ashraf Abu Jama, Ahron Yehonatan Cohen, Abed Agbarya
Publikováno v:
Biomedicines, Vol 11, Iss 9, p 2438 (2023)
Immune checkpoint inhibitors have become the standard of care in the treatment of metastatic non-small-cell lung cancer (NSCLC). The combination of nivolumab plus ipilimumab and chemotherapy has been shown to improve outcomes in terms of overall surv
Externí odkaz:
https://doaj.org/article/d217ee7737284174a6a3d089a1e8cd40
Publikováno v:
Cancers, Vol 15, Iss 16, p 4041 (2023)
Cutaneous squamous cell carcinoma (cSCC) of the skin is the second most common form of skin cancer, with aging and prolonged exposure to ultraviolet rays being the main causes of the disease. Cemiplimab and pembrolizumab recently gained regulatory ap
Externí odkaz:
https://doaj.org/article/4ccbc6a574c4444e8e39b0fd4c66e2f5
Autor:
Walid Shalata, Ismaell Massalha, Shlomo Yaron Ishay, Elena Chernomordikova, Ashraf Abu Jama, Keren Rouvinov, Yulia Dudnik, Alexander Yakobson
Publikováno v:
Life, Vol 13, Iss 7, p 1585 (2023)
In this particular case study, we present a 66-year-old male who was diagnosed with an atrial myxoma eight years after receiving treatment for non-small cell lung cancer. The patient underwent chemo-radiotherapy (mediastinal area) in 2012 to address
Externí odkaz:
https://doaj.org/article/43fdfc4b6d6e41ebbbb04ee2aadd8f56